Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals Inc (MIRM) is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
Maralixibat, is Mirum Pharmaceuticals lead product candidate. The product is an investigational oral drug in development for the following conditions:
- Alagille syndrome (ALGS)
- Progressive familial intrahepatic . . .
This content is for paid subscribers.Trick or Trade September 27, 2021